Nu Skin Enterprises, Inc. (NUS:NYSE) closed at $4.03 on November 13, 2026, up 0.50% on the day. The stock trades 65.5% below its 52-week high of $11.67 and 4.1% above its 52-week low of $3.87. Over the past year, it lost 58.1%. Nu Skin Enterprises, Inc. is part of the Health Care sector (Other Pharmaceuticals).
In 252 trading sessions since November 13, 2025, NUS closed higher on 121 days (48%). Its best day was June 26, 2026 (+6.88%) and its worst was February 13, 2026 (-18.12%). The stock moved 10% or more in a single session 1 time.
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC Transformation anti-aging skin care systems; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of aging, such as the influence of certain ingredients on gene expression. The company sells its products directly as well as through distributors, and its retail stores and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Find more stocks like NUS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.